ARCHIVES

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

Nature Editorial Criticizes NCI PR Spending

March 15, 2013

Core Grant Guideline Revisions, Comprehensive Center Characteristics Changes Still Coming Up

July 13, 1979

Clinical Research Group Of ACCC Meets

April 24, 1981

New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together

June 3, 1994

New England Medical Center Discloses Case Of Two Overdoses

April 28, 1995

Evidence Lacking On Value of Vitamins to Prevent Disease, Panel Says.

June 16, 2006